Next 10 |
home / stock / shgff / shgff news
TORONTO, June 24, 2021 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ: SLHG; TSXV:SLHG) (“Skylight Health” or the “Company”), a multi-state primary care management group in the United States, is pleased to announce that the Company has acquired the Doctor...
TORONTO, June 04, 2021 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (TSXV:SHG; OTCQX: SHGFF) (“Skylight Health” or the “Company”), a multi-state primary care management group in the United States, is pleased to announce that the Company's common shares will com...
Skylight Health (SHGFF) has signed a contract with Adagio Therapeutics to enroll patients into the Phase 2/3 trial evaluating monoclonal antibody, ADG20, designed to be a long-acting and broadly neutralizing antibody for both the treatment and prevention of COVID-19.The trial is a random...
Skylight Health has been selected as a clinical site to enroll patients for a clinical research trial investigating ADG20, a broadly neutralizing monoclonal antibody, for use in the prevention of COVID-19 The Skylight Health Research Team will work to bring industry-sponsore...
Skylight Health Group Inc. (SHGFF) Q1 2021 Earnings Conference Call June 1, 2021 9:00 am ET Company Participants Pradyum Sekar - Chief Executive Officer Andrew Elinesky - Chief Financial Officer Conference Call Participants Frank Takkinen - Lake Street Capital Markets Rob Goff - Echelon Capit...
CB2 Insights (SHGFF): Q1 Adjusted EBITDA of -$1.33MRevenue of $5.2M (+79.3% Y/Y)Press Release For further details see: CB2 Insights reports Q1 results
TORONTO, May 31, 2021 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (TSXV:SHG; OTCQX: SHGFF) (“Skylight Health” or the “Company”), a multi-state primary care management group in the United States, today announced its financial results for the first quarter ended...
Nasdaq confirmed that Skylight Health (SHGFF) will commence trading on Nasdaq during the June 7 week under the new symbol, "SLHG".This is subject to meeting the applicable bid price requirement for listing during the period commencing on the date of the company's share consolidation on M...
TORONTO, May 27, 2021 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (TSXV:SHG; OTCQX: SHGFF) (“Skylight Health” or the “Company”), a multi-state primary care management group in the United States, is pleased to announce that further to its press release dated Ma...
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, May 26, 2021 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (TSXV:SHG; OTCQX: SHGFF) (“Skylight Health” or the “Company”), a multi-state primary care ...
News, Short Squeeze, Breakout and More Instantly...
Skylight Health Group Inc Com Company Name:
SHGFF Stock Symbol:
OTCMKTS Market:
TORONTO, June 24, 2021 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ: SLHG; TSXV:SLHG) (“Skylight Health” or the “Company”), a multi-state primary care management group in the United States, is pleased to announce that the Company has acquired the Doctor...
TORONTO, June 04, 2021 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (TSXV:SHG; OTCQX: SHGFF) (“Skylight Health” or the “Company”), a multi-state primary care management group in the United States, is pleased to announce that the Company's common shares will com...
Skylight Health has been selected as a clinical site to enroll patients for a clinical research trial investigating ADG20, a broadly neutralizing monoclonal antibody, for use in the prevention of COVID-19 The Skylight Health Research Team will work to bring industry-sponsore...